Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid lymphoma. The case for combined modality therapy

R Doria1, J F Jekel, D L Cooper

  • 1Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06510.

Cancer
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recombinant activated factor VII in approved indications: Update on safety.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

Impact of pain and functional impairment in US adults with haemophilia: Patient-reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P-FiQ) study.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Self-reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

The Role of Rest and Relaxation.

The Physician and sportsmedicine·2016
Same author

Preventing Chest and Upper Abdominal Pain Associated With Exercise.

The Physician and sportsmedicine·2016
Same author

Developing and Testing Flexibility.

The Physician and sportsmedicine·2016

For thyroid lymphoma, combined modality treatment significantly reduces distant and overall recurrence rates compared to radiation therapy alone. This approach is crucial for improving outcomes in patients with localized disease.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Hematology

Background:

  • Thyroid lymphoma is typically treated with radiation therapy, with or without surgery.
  • The optimal role of chemotherapy and combined modality treatment remains unclear due to limited case numbers.

Purpose of the Study:

  • To evaluate the effectiveness of different treatment modalities for Stage I-II thyroid lymphoma.
  • To determine local and distant relapse rates following radiation therapy, chemotherapy, or combined modality treatment.

Main Methods:

  • Analysis of published literature and a Yale University series.
  • Inclusion criteria: Stage I-II thyroid lymphoma, anthracycline-based chemotherapy.
  • Exclusion criteria: Advanced disease, inadequate radiation, non-anthracycline regimens.

Related Experiment Videos

Main Results:

  • A total of 211 patients with Stage IE and IIE thyroid lymphoma were analyzed.
  • Combined modality treatment showed significantly lower distant and overall relapse rates.
  • Local relapse reduction was observed but not statistically significant.

Conclusions:

  • Thyroid lymphomas, despite a presumed low distant recurrence rate, have a 30% distant relapse risk in localized disease.
  • Adding chemotherapy to radiation therapy significantly reduces both distant and overall recurrence rates.